Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

The Indian government has launched a Financial Fraud Risk Indicator (FRI) which will block UPI transactions to mobile numbers ...